Home > Healthcare > Medical Devices > Diagnostic Devices > Carrier Screening Market

Carrier Screening Market Size

Report ID: GMI5759
Published Date: May 2023
Report Format: PDF

Download Free Sample

Carrier Screening Market Size

Carrier Screening Market size was valued at around USD 2 billion in 2023 and is anticipated to grow at a CAGR of over 13.1% between 2024 and 2032. Increasing awareness towards possibility of a genetic risks among couples, rise in adoption of cost-effective technologies for carrier screening, along with growing emphasis on early diagnosis of genetic diseases are expected to drive the industry growth over the forecast period.

To get key market trends

Download Free Sample

People with specific ethnicities or geographic backgrounds are more prone to be at risk of specific disorders. For instance, the American College of Obstetricians and Gynecologists (ACOG) recommends carrier screenings to parents from certain ethnicity such as the French-Canadian or Cajun descent for Tay-Sachs disease. Moreover, rise in adoption of carrier screening procedures and surging consumer interest towards personalized medicines are other factors anticipated to propel the carrier screening market expansion.

Carrier screening is a genetic testing that involves testing a sample of saliva, blood, or tissue from inside of the cheek. It is used to determine whether a healthy person is a carrier of a genetic disease. The healthcare professionals highly recommend couples to get this test done to check if they are at risk of having an offspring who is affected by any type of genetic complication

Carrier Screening Market Report Attributes
Report Attribute	Details
Base Year:	2023
Carrier Screening Market Size in 2023:	USD 2 Billion
Forecast Period:	2024 to 2032
Forecast Period 2024 to 2032 CAGR:	13.1%
2032 Value Projection:	USD 6 Billion
Historical Data for:	2018 to 2022
No. of Pages:	190
Tables, Charts & Figures:	428
Segments covered:	Type, Technology, Medical Condition, End-use and Region
Growth Drivers:	Rise in awareness coupled with emphasis on early diagnosis of genetic disorders Surging adoption of IVF and cryopreservation Technological advancements in carrier screening Growing consumer interest in personalized medicines
Pitfalls & Challenges:	High costs and reimbursement issues of carrier testing Lack of standard guidelines and skilled professionals

Learn more about the key segments shaping this market

Download Free Sample

Carrier screening for genetic diseases is among the widely established part of preconception and prenatal care especially in the developed world. Though carrier screening tests has long history, the industry has relatively limited regulatory guidelines available for providers leading to inconsistent practices. For example, countries including U.S., UK, Australia, and Canada have different guidelines for screening of cystic fibrosis carriers during pregnancy. Further, high cost of tests and lack of skilled professionals are predicted to impede the product adoption rate, thereby hampering the market growth over the analysis period.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market size for carrier screening was valued at around USD 2 billion in 2023 and is estimated to amass more than USD 6 billion by the end of 2032 owing to the increasing awareness of the possibility of genetic risks among couples.

The expanded carrier screening segment is expected to account for around USD 3.7 billion in 2032 attributed to the increasing product use in screening of multiple genetic disorders.

North America market for carrier screening is projected to reach over USD 2.3 billion by 2032 driven by the high R&D spending for different genetic complications and the availability of a wide range of carrier screening products.

Fulgent Genetics Inc., Thermo Fisher Scientific Inc., BGI Genomics, InVitae Corporation, Quest Diagnostics Inc., Illumina Inc., and Myriad Genetics, Inc. are some of the top companies in the global carrier screening market.